Ligand Completes Enrollment of Phase 1 Clinical Trial of Captisol-enabled Iohexol

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. OSIS
10. FMG:AU

Go back to Ligand Completes Enrollment of Phase 1 Clinical Trial of Captisol-enabled Iohexol
LIGAND PHARMA (NASDAQ: LGND) Delayed: 289.30 +1.91 (0.66%)
Previous Close $287.39    52 Week High $139.79 
Open $288.09    52 Week Low $82.07 
Day High $289.98    P/E 672.79 
Day Low $285.87    EPS $0.43 
Volume 41,515